Shandong Wohua Pharmaceutical Co., Ltd. logo

Shandong Wohua Pharmaceutical Co., Ltd. (002107)

Market Open
18 Apr, 06:57
XSHE XSHE
¥
4. 47
+0.03
+0.68%
¥
2.59B Market Cap
- P/E Ratio
1% Div Yield
5,636,600 Volume
- Eps
¥ 4.44
Previous Close
Day Range
4.4 4.55
Year Range
3.46 5.66

Summary

002107 trading today higher at ¥4.47, an increase of 0.68% from yesterday's close, completing a monthly increase of 0.45% or ¥0.02. Over the past 12 months, 002107 stock lost -1.32%.
002107 is not paying dividends to its shareholders.
The last earnings report, released on Oct 25, 2024, exceeded the consensus estimates by 0.02%. On average, the company has surpassed earnings expectations by 0.01%, based on the last three reports.
Shandong Wohua Pharmaceutical Co., Ltd. has completed 1 stock splits, with the recent split occurring on May 29, 2020.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSHE (CNY).
Want to track 002107 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

002107 Chart

Shandong Wohua Pharmaceutical Co., Ltd. (002107) FAQ

What is the stock price today?

The current price is ¥4.47.

On which exchange is it traded?

Shandong Wohua Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002107.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 2.59B.

Has Shandong Wohua Pharmaceutical Co., Ltd. ever had a stock split?

Shandong Wohua Pharmaceutical Co., Ltd. had 1 splits and the recent split was on May 29, 2020.

Shandong Wohua Pharmaceutical Co., Ltd. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Ms. Yingzi Zeng CEO
XSHE Exchange
CNE000001QB8 ISIN
CN Country
1,353 Employees
- Last Dividend
29 May 2020 Last Split
24 Jan 2007 IPO Date

Overview

Shandong Wohua Pharmaceutical Co., Ltd. is a leading pharmaceutical company in China, known for its comprehensive range of products and services tailored to meet various healthcare needs. Founded in 2003 and situated in Weifang, China, the company has established itself as a reputable player in the pharmaceutical industry. Its operation spans the manufacturing and sale of a diverse portfolio of pharmaceutical products, including traditional and modern medicines. It also extends its expertise to providing medical technology consulting services. With its roots embedded in Chinese pharmaceutical practices, Shandong Wohua Pharmaceutical Co., Ltd. succeeds in blending traditional Chinese medicine with contemporary medical advancements. The company functions as a subsidiary of Beijing Zhongzheng Wanrong Investment Group Co., Ltd., emphasizing its significant footprint in the pharmaceutical sector.

Products and Services

- **Cardiovascular and Cerebrovascular Disease Medications**:

Among its vast product range, Shandong Wohua Pharmaceutical Co., Ltd. offers several key medications designed to address cardiovascular and cerebrovascular diseases. These include Wohua Xinkeshu tablets and Holdan tablets and capsules, renowned for their effectiveness in treating these conditions. Additionally, the company provides Naoxueshu and Shenzhiling oral liquid, and Tongluo Huatan capsules, offering a variety of administration routes to suit patient preferences and medical requirements.

- **Musculoskeletal Disorder Treatments**:

To cater to patients with musculoskeletal disorders, the company has developed Gushukang capsules/granules, Yuandu Hanbi liquid, and Kite cold paralysis medicine liquor. These treatments are tailored to alleviate symptoms and improve the quality of life for individuals suffering from these debilitating conditions.

- **Urinary System Diseases**:

Addressing the needs of patients with urinary system diseases, Shandong Wohua Pharmaceutical Co., Ltd. provides Amber hydrazine particles. This product is formulated to tackle various urinary conditions effectively, ensuring patient comfort and health.

- **Pediatric Medicine**:

Understanding the specific health challenges faced by children, the company offers Pediatric Antipyretic granules. Designed for the younger population, these granules are formulated to reduce fever safely and effectively, addressing a common health concern among children.

- **Skin Disease Medications**:

For individuals dealing with skin diseases, the company has created Anti-ginseng anti-itch particles. This product aims to alleviate itching and discomfort associated with various skin conditions, offering patients relief and improved skin health.

- **Digestive and Gynecological Health**:

Shandong Wohua Pharmaceutical Co., Ltd. offers Echinacea capsules to support digestive and gynecological health. This herbal supplement is crafted to enhance the body's natural defenses while providing specific benefits to the digestive system and female reproductive health.

- **Blood Nourishment and Kidney Support**:

Lastly, the company’s product line includes Siyu Yangxue Yishen granules. These granules are designed to nourish the blood and support kidney health, reflecting the company’s holistic approach to healthcare and wellness.

Contact Information

Address: No. 3517 Liyuan Street, Weifang, China, 261205
Phone: 86 53 6855 3373